Shinichi Koizumi

Person

Aichi, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 11,840,530
- Issue date Dec 12, 2023
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,947,235
- Issue date Mar 16, 2021
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,611,761
- Issue date Apr 7, 2020
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of EP4 receptor antagonists for the treatment of NASH-associate...
- Patent number 10,583,129
- Issue date Mar 10, 2020
- AskAt Inc.
- Naoko Ohtani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of benzimidazole derivative for nocturnal acid breakthrough
- Patent number 10,512,635
- Issue date Dec 24, 2019
- CJ HealthCare Corporation
- Ha Jin Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of EP4 receptor antagonists for the treatment of NASH-associate...
- Patent number 10,342,785
- Issue date Jul 9, 2019
- AskAt Inc.
- Naoko Ohtani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists
- Patent number 9,901,571
- Issue date Feb 27, 2018
- Raqualia Pharma Inc.
- Yasuhiro Iwata
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serine derivatives as ghrelin receptor agonists
- Patent number 9,873,695
- Issue date Jan 23, 2018
- Raqualia Pharma Inc.
- Yasuhiro Iwata
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 9,688,674
- Issue date Jun 27, 2017
- AskAt Inc.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic agent for ocular disease
- Patent number 9,561,210
- Issue date Feb 7, 2017
- AskAt Inc.
- Takako Okumura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of EP4 receptor antagonists in the treatment of IL-23 mediated...
- Patent number 9,457,084
- Issue date Oct 4, 2016
- Raqualia Pharma Inc.
- Kiyoshi Kanazawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 8,921,391
- Issue date Dec 30, 2014
- Raqualia Pharma Inc.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acid pump antagonist for the treatment of diseases involved in abno...
- Patent number 8,648,080
- Issue date Feb 11, 2014
- Raqualia Pharma Inc.
- Nobuyuki Takahashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20220073510
- Publication date Mar 10, 2022
- AskAt Inc.
- Yukinori TAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH
- Publication number 20200069652
- Publication date Mar 5, 2020
- CJ HEALTHCARE CORPORATION
- Ha Jin LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20190365680
- Publication date Dec 5, 2019
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20190269663
- Publication date Sep 5, 2019
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH
- Publication number 20180338954
- Publication date Nov 29, 2018
- CJ HEALTHCARE CORPORATION
- Ha Jin LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...
- Publication number 20180125832
- Publication date May 10, 2018
- AskAt Inc.
- Naoko OHTANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAHYDROPYRAZOLOPYRIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS
- Publication number 20170304277
- Publication date Oct 26, 2017
- RAQUALIA PHARMA INC.
- Yasuhiro IWATA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20170253595
- Publication date Sep 7, 2017
- AskAt Inc.
- Yukinori TAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS
- Publication number 20170197961
- Publication date Jul 13, 2017
- RAQUALIA PHARMA INC.
- Yasuhiro IWATA
- G01 - MEASURING TESTING
Information Patent Application
THERAPEUTIC AGENT FOR OCULAR DISEASE
- Publication number 20160008317
- Publication date Jan 14, 2016
- AskAt Inc.
- Takako OKUMURA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20150111920
- Publication date Apr 23, 2015
- RAQUALIA PHARMA INC.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF IL-23 MEDIATED...
- Publication number 20120316197
- Publication date Dec 13, 2012
- RAQUALIA PHARMA INC.
- Kiyoshi Kanazawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACID PUMP ANTAGONIST FOR THE TREATMENT OF DISEASES INVOLVED IN ABNO...
- Publication number 20120115820
- Publication date May 10, 2012
- Raqualia Pharma Inc.
- Nobuyuki Takahashi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR AGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20120088723
- Publication date Apr 12, 2012
- RAQUALIA PHARMA INC.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Shinichi Koizumi

Person

Patents Grantslast 30 patents

Selective EP4 receptor antagonistic substance for treatment of cancer

Selective EP4 receptor antagonistic substance for treatment of cancer

Selective EP4 receptor antagonistic substance for treatment of cancer

Use of EP4 receptor antagonists for the treatment of NASH-associate...

Uses of benzimidazole derivative for nocturnal acid breakthrough

Use of EP4 receptor antagonists for the treatment of NASH-associate...

Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists

Serine derivatives as ghrelin receptor agonists

Selective EP4 receptor antagonistic substance for treatment of cancer

Therapeutic agent for ocular disease

Use of EP4 receptor antagonists in the treatment of IL-23 mediated...

Selective EP4 receptor antagonistic substance for treatment of cancer

Acid pump antagonist for the treatment of diseases involved in abno...

Patents Applicationslast 30 patents

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATE...

TETRAHYDROPYRAZOLOPYRIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS

THERAPEUTIC AGENT FOR OCULAR DISEASE

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF IL-23 MEDIATED...

ACID PUMP ANTAGONIST FOR THE TREATMENT OF DISEASES INVOLVED IN ABNO...

SELECTIVE EP4 RECEPTOR AGONISTIC SUBSTANCE FOR TREATMENT OF CANCER